|
*Living Combination
|
|
IRF-LTCH-SNF
|
Ref.
| | | |
|
SNF-only
|
5.443
|
5.318
|
5.571
|
< 0.001
|
|
LTCH-SNF
|
4.043
|
3.835
|
4.262
|
< 0.001
|
|
IRF-only
|
6.796
|
3.754
|
12.303
|
< 0.001
|
|
IRF-SNF
|
1.397
|
1.363
|
1.432
|
< 0.001
|
|
*Age, yrs
|
|
21–64
|
0.986
|
0.942
|
1.033
|
0.621
|
|
65–69
|
Ref.
| | | |
|
70–74
|
0.936
|
0.901
|
0.971
|
0.003
|
|
75–79
|
0.856
|
0.825
|
0.887
|
< 0.001
|
|
80–84
|
0.727
|
0.702
|
0.754
|
< 0.001
|
|
85+
|
0.622
|
0.601
|
0.643
|
< 0.001
|
|
*Race
|
|
Non-Hispanic White
|
Ref.
| | | |
|
Non-Hispanic Black
|
1.058
|
1.027
|
1.089
|
0.001
|
|
Hispanic
|
1.138
|
1.090
|
1.188
|
< 0.001
|
|
Other
|
1.333
|
1.269
|
1.401
|
< 0.001
|
|
*Sex
|
|
Male
|
Ref.
| | | |
|
Female
|
0.960
|
0.942
|
0.978
|
< 0.001
|
|
Stroke Type
|
|
Ischemic
|
Ref.
| | | |
|
Hemorrhagic
|
1.012
|
0.983
|
1.043
|
0.493
|
|
*Acute LOS, days
|
|
0–3
|
Ref.
| | | |
|
4–7
|
1.030
|
1.010
|
1.051
|
0.015
|
|
8–11
|
1.032
|
1.000
|
1.065
|
0.098
|
|
12–25
|
1.089
|
1.045
|
1.135
|
0.001
|
|
26+
|
1.185
|
1.038
|
1.353
|
0.035
|
|
*Dual Eligible
|
|
No
|
Ref.
| | | |
|
Yes
|
0.769
|
0.752
|
0.787
|
< 0.001
|
|
*ICU/CCU
|
|
No
|
Ref.
| | | |
|
Yes
|
1.259
|
1.236
|
1.283
|
< 0.001
|
|
*Hemiplegia/Hemiparesis
|
1.191
|
1.169
|
1.213
|
< 0.001
|
|
Specified Heart Arrhythmias
|
0.998
|
0.978
|
1.018
|
0.856
|
|
*Diabetes without Complications
|
0.969
|
0.949
|
0.989
|
0.011
|
|
Congestive Heart Failure
|
0.982
|
0.960
|
1.004
|
0.176
|
|
*Acute Renal Failure
|
1.041
|
1.015
|
1.068
|
0.008
|
|
*Chronic Obstructive Pulmonary Disease
|
0.920
|
0.897
|
0.943
|
< 0.001
|
|
Vascular Disease
|
0.994
|
0.967
|
1.022
|
0.715
|
|
*Diabetes with Chronic Complications
|
0.935
|
0.903
|
0.969
|
0.002
|
|
*Seizure Disorders and Convulsions
|
0.916
|
0.885
|
0.948
|
< 0.001
|
|
Cardio-Respiratory Failure and Shock
|
1.003
|
0.966
|
1.042
|
0.881
|
